Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 2
1986 1
1996 2
2001 1
2003 3
2007 1
2010 2
2013 2
2014 1
2015 1
2017 3
2018 2
2019 2
2021 2
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
A practical approach to hypercalcemia.
Carroll MF, Schade DS. Carroll MF, et al. Am Fam Physician. 2003 May 1;67(9):1959-66. Am Fam Physician. 2003. PMID: 12751658 Free article. Review.
The diagnosis often is made incidentally in asymptomatic patients. Clinical manifestations affect the neuromuscular, gastrointestinal, renal, skeletal, and cardiovascular systems. ...Some other important causes of hypercalcemia are medications and familial hypoca
The diagnosis often is made incidentally in asymptomatic patients. Clinical manifestations affect the neuromuscular, gastrointestinal …
Personalised medicines for familial hypercalcemia and hyperparathyroidism.
Josephs TM, Zhang F, Dinh LV, Keller AN, Conigrave AD, Capuano B, Gregory KJ, Leach K. Josephs TM, et al. J Mol Endocrinol. 2022 May 9;69(1):243-257. doi: 10.1530/JME-21-0263. J Mol Endocrinol. 2022. PMID: 35318962
Loss-of-function calcium-sensing receptor (CASR) mutations cause mineral metabolism disorders, familial hypocalciuric hypercalcemia, or neonatal severe hyperparathyroidism and increase the risk of femoral fracture, chronic kidney disease, coronary heart disea …
Loss-of-function calcium-sensing receptor (CASR) mutations cause mineral metabolism disorders, familial hypocalciuric hyper
Calcimimetic Use in Familial Hypocalciuric Hypercalcemia-A Perspective in Endocrinology.
Marx SJ. Marx SJ. J Clin Endocrinol Metab. 2017 Nov 1;102(11):3933-3936. doi: 10.1210/jc.2017-01606. J Clin Endocrinol Metab. 2017. PMID: 28945857 Free PMC article. Review.
CONTEXT: Familial hypocalciuric hypercalcemia (FHH) causes lifelong hypercalcemia that even persists after subtotal parathyroidectomy. ...
CONTEXT: Familial hypocalciuric hypercalcemia (FHH) causes lifelong hypercalcemia that even persists after subtotal par …
Hypercalcemia in children and adolescents.
Lietman SA, Germain-Lee EL, Levine MA. Lietman SA, et al. Curr Opin Pediatr. 2010 Aug;22(4):508-15. doi: 10.1097/MOP.0b013e32833b7c23. Curr Opin Pediatr. 2010. PMID: 20601885 Free PMC article. Review.
RECENT FINDINGS: One rare cause of hypercalcemia in the child is familial hypocalciuric hypercalcemia (also termed familial benign hypercalcemia). ...In this review, we have distinguished the neonate and infant from the older child and adolescent because the …
RECENT FINDINGS: One rare cause of hypercalcemia in the child is familial hypocalciuric hypercalcemia (also termed fami …
Cinacalcet Reverses Short QT Interval in Familial Hypocalciuric Hypercalcemia Type 1.
Cuny T, Romanet P, Goldsworthy M, Guérin C, Wilkin M, Roche P, Sebag F, van Summeren LE, Stevenson M, Howles SA, Deharo JC, Thakker RV, Taïeb D. Cuny T, et al. J Clin Endocrinol Metab. 2024 Jan 18;109(2):549-556. doi: 10.1210/clinem/dgad494. J Clin Endocrinol Metab. 2024. PMID: 37602721 Free PMC article.
CONTEXT: Familial hypocalciuric hypercalcemia type 1 (FHH-1) defines an autosomal dominant disease, related to mutations in the CASR gene, with mild hypercalcemia in most cases. ...
CONTEXT: Familial hypocalciuric hypercalcemia type 1 (FHH-1) defines an autosomal dominant disease, related to mutation …
Cinacalcet therapy in a child with novel homozygous CASR p.Glu353Lys mutation causing familial hypocalciuric hypercalcemia type 1: case report and review of the literature.
Koca SB. Koca SB. Turk J Pediatr. 2023;65(5):853-861. doi: 10.24953/turkjped.2022.1040. Turk J Pediatr. 2023. PMID: 37853976 Free article. Review.
BACKGROUND: Familial hypocalciuric hypercalcemia (FHH) is one of the conditions that should be considered in the differential diagnosis of hypercalcemia and normo-hypophosphatemia in childhood. ...CONCLUSIONS: FHH can be seen in heterozygous as well as homozy …
BACKGROUND: Familial hypocalciuric hypercalcemia (FHH) is one of the conditions that should be considered in the differ …
Cinacalcet corrects hypercalcemia in mice with an inactivating Gα11 mutation.
Howles SA, Hannan FM, Gorvin CM, Piret SE, Paudyal A, Stewart M, Hough TA, Nesbit MA, Wells S, Brown SD, Cox RD, Thakker RV. Howles SA, et al. JCI Insight. 2017 Oct 19;2(20):e96540. doi: 10.1172/jci.insight.96540. JCI Insight. 2017. PMID: 29046478 Free PMC article.
Loss-of-function mutations of GNA11, which encodes G-protein subunit alpha11 (Galpha11), a signaling partner for the calcium-sensing receptor (CaSR), result in familial hypocalciuric hypercalcemia type 2 (FHH2). FHH2 is characterized by hypercalcemia, inappro …
Loss-of-function mutations of GNA11, which encodes G-protein subunit alpha11 (Galpha11), a signaling partner for the calcium-sensing recepto …
Cinacalcet monotherapy in neonatal severe hyperparathyroidism: a case study and review.
Gannon AW, Monk HM, Levine MA. Gannon AW, et al. J Clin Endocrinol Metab. 2014 Jan;99(1):7-11. doi: 10.1210/jc.2013-2834. Epub 2013 Dec 20. J Clin Endocrinol Metab. 2014. PMID: 24203066 Free PMC article. Review.
CONTEXT: Neonatal severe hyperparathyroidism (NSHPT) is a severe form of familial hypocalciuric hypercalcemia characterized by severe hypercalcemia and skeletal demineralization. ...The rapid and durable response to cinacalcet suggests that a trial of …
CONTEXT: Neonatal severe hyperparathyroidism (NSHPT) is a severe form of familial hypocalciuric hypercalcemia character …
Amelioration of hypercalcemia by cinacalcet treatment in a subject with relapsing acquired hypocalciuric hypercalcemia: A case report.
Sanada J, Kamei S, Shimoda M, Tatsumi F, Kimura T, Obata A, Kohara K, Nakanishi S, Kaku K, Mune T, Kaneto H. Sanada J, et al. Medicine (Baltimore). 2021 Oct 22;100(42):e27579. doi: 10.1097/MD.0000000000027579. Medicine (Baltimore). 2021. PMID: 34678905 Free PMC article.
RATIONALE: Hypocalciuric hypercalcemia is classified as acquired hypocalciuric hypercalcemia (AHH) and familial hypocalciuric hypercalcemia (FHH). While FHH is inherited as an autosomal dominant trait, AHH is one of the rare acquired diseases and is usually t …
RATIONALE: Hypocalciuric hypercalcemia is classified as acquired hypocalciuric hypercalcemia (AHH) and familial hypocalciuric
28 results